Navigation Links
Pediatric Associates of Jacksonville Announces New Integrative Medicine Services for Children with Autism Spectrum Disorders
Date:9/10/2013

Jacksonville, FL (PRWEB) September 10, 2013

Bio Regulation Therapy (BRT) is the next phase of integrative and functional approaches to health and wellness. Pediatric Associates of Jacksonville has harnessed the use of advanced technology and innate biological communication processes to support, optimize, and regulate the body at a cellular level. The practice’s new study, the Behavior Support Program, analyzes the impact of BRT as a stand-alone therapy, support modality to other therapies, as well as a support in decreasing Autism Spectrum Disorder (ASD) patient’s resistance to other rehabilitative therapy.

The pilot study, initiated in May this year, is a Behavior Support Program, that provides supportive treatment and assesses the effectiveness of BRT applied for ASD patient’s and, more generally, behaviorally-challenged children ages 3-18. BRT can be used to help a variety of specific imbalances and conditions, as well as preventatively to maintain overall balance and wellness. BRT clinical applications have been proven to provide benefits in medical conditions like allergies, sports medicine injuries and recovery, and overall health issues like circulation and inflammation.

Every organ in the body has its own bioelectricmagentic field, and all 70 billion cells communicate via electromagnetic fields. When communications between cells are interrupted, the body’s cells, tissues and organs are compromised and unhealthy symptoms follow. Pediatric Associates or Jacksonville utilizes Lenyo Devices to provide BRT. These unique devices deliver safe, extremely low intensity signals at the cellular level, in order to induce the body’s own self-regulation process. Lenyo BRT devices are one of a kind in that they feature an advanced signaling technology that enables extreme precision when targeting cells in the body.

The research team at Pediatric Associates of Jacksonville performs experimental research on functional or bio-informatic approaches to pediatric healthcare. For the purposes of the Behavior Support Program pilot study, the team has partnered with technology providers, academic institutions, laboratory and Neuro-feedback EEG facilities, as well as child support non-profit organizations.

About Pediatric Associates of Jacksonville:

Pediatric Associates of Jacksonville originally opened in 1932 and now operates in three locations located in Jacksonville, Julington Creek and Ponte Vedra, Florida for patients ranging from newborns to 21. Today, Pediatric Associates of Jacksonville is led by Dr. Aylin Ozdemir, winner of the 2012 and 2011 Patients’ Choice Award, which is a distinction received by less than 5 percent of America’s practicing physicians. Dr. O recently finished her Integrative Medicine fellowship led by Dr. Andrew Weil at The University of Arizona. The Integrative practice of combining traditional and alternative medicine distinguishes her from every other General Practitioner in the State of Florida. To learn more about Pediatric Associates of Jacksonville call 904-273-6533 or visit our website at DoctorOJax.com.

Read the full story at http://www.prweb.com/releases/2013/9/prweb11105535.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Discovery Labs to Present AFECTAIR® Data at European Congress on Pediatric and Neonatal Ventilation
2. Top 10 “Best Children’s Hospitals” Include 3 Pediatric Centers Offering SynCardia Total Artificial Heart
3. PROLOR Biotech to Present Data on Its Long-Acting Human Growth Hormone at Pediatric Endocrinology Meeting
4. Tumor Paint Research Of Pediatric Oncologist Jim Olson Featured In Short Film -- A Sundance Festival Semifinalist
5. CSL Behring enrolls first patient in global pediatric Phase III pivotal study of recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) to treat hemophilia B
6. University of Colorado Cancer Center Review Shows Long-term Side-effects of New, Targeted Therapies in Pediatric Cancer Patients
7. University of Colorado Cancer Center Study Shows the Preferred Feeding Method is not the Medically Best in Malnourished Pediatric Cancer Patients
8. Mayo Clinic and ReachMD Launch “Updates from Mayo Clinic” Featuring Expert Interviews and Panel Discussions on Mental Health in Pediatric Primary Care
9. 1st Pediatric SynCardia Total Artificial Heart Patient in Turkey Celebrates 18th Birthday
10. Pediatric Feeding Institute Revolutionizes the Treatment of Childrens Feeding Disorders with Mealtime Miseries Live Seminars
11. PinneyAssociates Announces Senior Staff Promotions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/12/2018)... ... 2018 , ... Leading regenerative veterinary medicine company, VetStem Biopharma, ... later this month. The company’s CEO and founder, Dr. Robert Harman, ... chronic kidney disease in felines at a poster session on Saturday, September 29th. ...
(Date:9/12/2018)... Va. (PRWEB) , ... September 12, 2018 , ... ... Lauren Bronich-Hall, a quality management professional and former Senior Director of Regulatory Affairs ... Consultant. , As Senior Director of Regulatory Affairs and Quality Systems at ...
(Date:9/7/2018)... ... September 06, 2018 , ... The Discovery on Target (DOT) ... “The industry’s preeminent event on novel drug targets.” BellBrook Labs’ high throughput screening ... these emerging targets in a quest to find new treatments for disease. , ...
(Date:9/7/2018)... ... September 06, 2018 , ... Flagship Biosciences’ MuscleMap algorithm ... to be as effective as manual pathology. The study, “Validation of a Muscle-Specific ... was published in the Archives of Pathology & Laboratory Medicine on August 31, ...
Breaking Biology Technology:
(Date:8/31/2018)... ... August 30, 2018 , ... CallTower is pleased ... more than 20-years of telecommunications experience and over ten years in executive leadership. Prior ... acquired by CallTower in early 2018. , In this new role, Jason ...
(Date:8/31/2018)... ... 2018 , ... USDM Life Sciences , the leading risk management, technological ... received the 2018 Services Partner of the Year, Awarded for Innovation from Box, a ... Development and Platform Sales, Niall Wall and received by USDM Life Sciences CEO, Kevin ...
(Date:8/29/2018)... , ... August 28, 2018 ... ... radiopharmaceutical company unlocking the full power of positron emission tomography (PET), today ... catalysis, Fuzionaire Dx is helping clinicians and researchers study and cure debilitating ...
Breaking Biology News(10 mins):